Windlas Biotech Limited — Board Meeting, 22-05-2025: Outcome of Board Meeting

Windlas Biotech has announced a board meeting on the approval of consolidated financial results for the quarter and year ended March 31, 2025. The company reported revenue of Rs. 759.88 Cr and net profit of Rs. 60.99 Cr for the year. It declared a dividend of Rs. 5.80 per share. Windlas Inc., its wholly-owned subsidiary, exited the joint venture USpharma Windlas LLC. The company allotted 1.6 lakh shares under its ESOP, maintaining focus on employee incentives, and invested significantly in capacity expansion with property, plant, and equipment rising to Rs. 195.49 Cr.